TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...

Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI —TOKYO, March 12, 2026 ...

When natural disasters or extreme weather events hit, delivering aid quickly and efficiently to those affected is crucial.

How NASA's F-15 ACTIVE program tested thrust vectoring and adaptive controls to improve performance of future ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...